Clinical Trial Update: BD OneFlow CLPD Panel (BD OneFlow LST, and B-CLPD T1 to T4 Assays) on the BD FACSLyric System.

View source ↗

Summary

A clinical trial evaluating the BD OneFlow CLPD Panel on the BD FACSLyric system has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoproliferative Diseases

Snippet

Sponsor: Becton, Dickinson and Company | Conditions: Chronic Lymphoproliferative Diseases (CLPD) | Status: COMPLETED